Treatment using medications that adjust the immune system's activity to slow the progression and reduce the frequency and severity of relapses in multiple sclerosis.
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system. Immunomodulatory therapies aim to modify the disease course, not cure it. These therapies are prescribed based on disease activity, patient characteristics, and potential risks and benefits.
"Initiate immunomodulatory therapy with [Specific medication name] for relapsing-remitting MS."
Used when discussing treatment strategies to manage the progression of MS. Includes decisions about starting, changing, or continuing treatment.
Common questions about using medical phrases in clinical documentation